C3 and metabolic dysfunction-associated steatotic liver disease: A Turkish case-control study involving 46 NAFLD patients demonstrated that the level of Complement component C3 was significantly higher in peripheral blood of NAFLD patients than that of healthy control group and chronic hepatitis B control group (12).